We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...
CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...
In a major belt-tightening measure, Police Chief Thomas Morse Jr. said he's ending a $400,000 annual contract with a company that's provided the city for 18 years with sensor technology.